AIELLO, ANNA
 Distribuzione geografica
Continente #
AS - Asia 56
EU - Europa 52
NA - Nord America 51
SA - Sud America 13
Totale 172
Nazione #
US - Stati Uniti d'America 51
SG - Singapore 26
HK - Hong Kong 15
BR - Brasile 11
GB - Regno Unito 11
RU - Federazione Russa 9
DE - Germania 7
ID - Indonesia 7
CN - Cina 5
FI - Finlandia 5
NL - Olanda 5
IT - Italia 4
SE - Svezia 4
AT - Austria 3
LT - Lituania 3
AZ - Azerbaigian 2
BO - Bolivia 1
EC - Ecuador 1
FR - Francia 1
LK - Sri Lanka 1
Totale 172
Città #
Santa Clara 36
Singapore 20
Hong Kong 15
London 8
Jakarta 6
Lappeenranta 3
Los Angeles 3
Amsterdam 2
Baku 2
Bedworth 2
Frankfurt am Main 2
Helsinki 2
Vienna 2
Aparecida do Taboado 1
Ashburn 1
Bologna 1
Buracão 1
Canoas 1
Castanhal 1
Colombo 1
Cuenca 1
Dallas 1
Düsseldorf 1
Ferrara 1
Goiânia 1
La Paz 1
Lauterbourg 1
Matipó 1
Moscow 1
Munich 1
Nuremberg 1
Pindamonhangaba 1
Piracicaba 1
Praia Grande 1
Reggio Emilia 1
San Francisco 1
Santa Isabel do Pará 1
São Paulo 1
Wandsworth 1
Totale 129
Nome #
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry 63
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 54
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry 44
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 15
Totale 176
Categoria #
all - tutte 2.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202434 0 0 0 6 4 0 6 1 2 2 6 7
2024/2025142 4 2 9 7 29 40 16 6 25 4 0 0
Totale 176